Mirvaso Side Effects
Generic name: brimonidine topical
Medically reviewed by Drugs.com. Last updated on Jan 31, 2021.
Note: This document contains side effect information about brimonidine topical. Some of the dosage forms listed on this page may not apply to the brand name Mirvaso.
Common side effects of Mirvaso include: flushing. Other side effects include: burning sensation of skin and erythema of skin. See below for a comprehensive list of adverse effects.
For the Consumer
Applies to brimonidine topical: topical application gel/jelly
Side effects requiring immediate medical attention
Along with its needed effects, brimonidine topical (the active ingredient contained in Mirvaso) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking brimonidine topical:
- Flushing or redness of the skin
- unusually warm skin
- Blemishes on the skin
- blistering, burning, crusting, dryness, or flaking of the skin
- itching, scaling, severe redness, soreness, or swelling of the skin
Side effects not requiring immediate medical attention
Some side effects of brimonidine topical may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
- Blurred vision
- burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
- muscle aches
- sore throat
- stuffy or runny nose
- unusual tiredness or weakness
For Healthcare Professionals
Applies to brimonidine topical: topical gel
Uncommon (0.1% to 1%): Dry skin, skin discomfort, papular rash
Common (1% to 10%): Nasal congestion, nasopharyngitis, upper respiratory track infection
Postmarketing reports: Throat tightness[Ref]
Common (1% to 10%): Blurred vision, increased intraocular pressure
Common (1% to 10%): Headache, paresthesia
Common (1% to 10%): Flushing
Uncommon (0.1% to 1%): Feeling hot, peripheral coldness[Ref]
Uncommon (0.1% to 1%): Dry mouth
Postmarketing reports: Lip swelling, tongue swelling[Ref]
Postmarketing reports: Application site pallor, excessive whitening at application site[Ref]
More about Mirvaso (brimonidine topical)
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- Pricing & Coupons
- En Español
- 165 Reviews
- Drug class: topical anti-rosacea agents
- FDA Approval History
Related treatment guides
1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
2. "Product Information. Mirvaso (brimonidine topical)." Galderma Laboratories Inc, Cranbury, NJ.
3. Cerner Multum, Inc. "Australian Product Information." O 0
Some side effects may not be reported. You may report them to the FDA.